Nichols Institute
Melanoma Risk May Be Higher in Parkinson's Disease                    Technique Shows Potential of Bapineuzumab in Alzheimer's                    Female Moderate Drinkers May Be Less Likely to Gain Weight                    CT Scan Cost-Effective Way to Screen for Lung Condition                    Benefit Not Seen From Adding Sorafenib in Lung Cancer                   
Skip Navigation Links
Home

Home
|
Nichols Access

Nichols Access
|
Nichols Library

Nichols Library
|
Nichols Tour

Lab Info
|
Lab Info

Lab Info
SIGN IN
Search Test Selection and Interpretation
SEARCH TEST LIST
Test Name Test Code Keyword
a b c d e f g h i j k l m
n o p q r s t u v w x y z
Skip Navigation Links
  Directory of ServicesExpand   Directory of Services
  Allergy & ImmunologyExpand   Allergy & Immunology
  CardiovascularExpand   Cardiovascular
  CoagulationExpand   Coagulation
  EndocrinologyExpand   Endocrinology
  GeneticsExpand   Genetics
  Hematology | OncologyExpand   Hematology | Oncology
  Infectious DiseasesExpand   Infectious Diseases
  PediatricsExpand   Pediatrics
  TransplantExpand   Transplant
Specimen Handling –
General Requirements

Testing By Disease State

Hemostasis Disorders (Bleeding and Hypercoagulability)
Heparin-Induced Thrombocytopenia (HIT)
Intravascular Coagulation (Local and Disseminated)
Phospholipid Antibody Syndrome
Platelet Immune Disorder
Screen for Coagulation Disorders
Therapeutic Monitoring
Thrombophilic Disorders
von Willebrand’s Disease
Women’s Health

 Test NameTest Code
  Factor II Activity, Clotting
  Factor IX Activity and Human Inhibitor
  Factor IX Activity, Clotting
  Factor V Activity and Human Inhibitor
  Factor VII Activity, Clotting
  Factor VIII Activity, Chromogenic
  Factor VIII Activity, Clotting
  Factor VIII Inhibitor Panel
  Factor X Activity, Chromogenic
  Factor X Activity, Clotting
  Factor XI Activity, Clotting
  Factor XI Mutation Analysis (Ashkenazi Jewish)
  Factor XII Activity, Clotting
  Factor XIII, Functional
  Fibrinolysis Comprehensive Panel
Includes a2-antiplasmin, D-dimer, euglobulin clot lysis time, fibrin monomer, fibrinogen degradation products, PAI-1 activity, functional plasminogen levels, and TPA and interpretation
  Plasminogen Activator Inhibitor (PAI-1) Activity
  Plasminogen Activator Inhibitor -1 (PAI-1) 4G/5G Polymorphism
  Plasminogen Activator Inhibitor-1, Antigenic
  Prekallikrein (Fletcher Factor) Activity
  Prothrombin Fragment 1.2
  Reptilase Clotting Time (Fibrinogen)
  Thrombin Clotting Time
  Thrombin Clotting Time with Reflex to Mixing Study
  Alpha-2-Antiplasmin